Paper24204366
Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.
Flingai S and 5 others. Front Immunol, 2013. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Papers, record 24204366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24204366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI092843 | NIAID NIH HHS | United States | R01AI092843 | PubMed and NIH |
Source NIH RePORTER
References139
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15972637 | Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. | J Immunol | 2005 | https://conductscience.org/library/papers/15972637 | PubMed |
| 2 | 15613305 | Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. | J Virol | 2005 | https://conductscience.org/library/papers/15613305 | PubMed |
| 3 | 1545867 | Genetic immunization is a simple method for eliciting an immune response. | Nature | 1992 | https://conductscience.org/library/papers/1545867 | PubMed |
| 4 | 9637479 | Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. | J Immunol | 1998 | https://conductscience.org/library/papers/9637479 | PubMed |
| 5 | 9739045 | CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9739045 | PubMed |
| 6 | 17335943 | Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. | Vaccine | 2007 | https://conductscience.org/library/papers/17335943 | PubMed |
| 7 | 19118066 | A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19118066 | PubMed |
| 8 | 11983262 | Issues for improving multiplasmid DNA vaccines for HIV-1. | Vaccine | 2002 | https://conductscience.org/library/papers/11983262 | PubMed |
| 9 | 23052295 | Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. | Sci Transl Med | 2012 | https://conductscience.org/library/papers/23052295 | PubMed |
| 10 | 18781156 | DNA vaccines: ready for prime time? | Nat Rev Genet | 2008 | https://conductscience.org/library/papers/18781156 | PubMed |
| 11 | 9414251 | Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. | Hum Gene Ther | 1997 | https://conductscience.org/library/papers/9414251 | PubMed |
| 12 | 16226783 | DNA immunization using a non-viral promoter. | Virology | 2006 | https://conductscience.org/library/papers/16226783 | PubMed |
| 13 | 23255562 | Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23255562 | PubMed |
| 14 | 21530212 | Electroporation delivery of DNA vaccines: prospects for success. | Curr Opin Immunol | 2011 | https://conductscience.org/library/papers/21530212 | PubMed |
| 15 | 23684840 | Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. | Vaccine | 2013 | https://conductscience.org/library/papers/23684840 | PubMed |
| 16 | 11070014 | DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. | J Virol | 2000 | https://conductscience.org/library/papers/11070014 | PubMed |
| 17 | 11407402 | Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout oncorhynchus mykiss using DNA vaccines. | Dis Aquat Organ | 1999 | https://conductscience.org/library/papers/11407402 | PubMed |
| 18 | 15546399 | The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. | Immunol Rev | 2004 | https://conductscience.org/library/papers/15546399 | PubMed |
| 19 | 23635778 | PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23635778 | PubMed |
| 20 | 12641651 | DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. | Scand J Immunol | 2003 | https://conductscience.org/library/papers/12641651 | PubMed |
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42515602 | Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives. | Viruses | 2026 | https://conductscience.org/library/papers/42515602 | PubMed |
| 42511592 | A Spike-Linked HPV16 E7 DNA Vaccine Induces Potent Antitumor and Anti-Spike Immune Responses. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511592 | PubMed |
| 42338313 | Biomaterial-Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation. | Small | 2026 | https://conductscience.org/library/papers/42338313 | PubMed |
| 40230522 | Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques. | iScience | 2025 | https://conductscience.org/library/papers/40230522 | PubMed |
| 40120578 | Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40120578 | PubMed |
| 38473422 | Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473422 | PubMed |
| 38250884 | DNA Vaccines: Their Formulations, Engineering and Delivery. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38250884 | PubMed |
| 38033486 | The power of phages: revolutionizing cancer treatment. | Front Oncol | 2023 | https://conductscience.org/library/papers/38033486 | PubMed |
| 37725199 | Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development. | Cell Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37725199 | PubMed |
| 37547674 | Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37547674 | PubMed |
| 36807845 | Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | https://conductscience.org/library/papers/36807845 | PubMed |
| 36389680 | Strategy of developing nucleic acid-based universal monkeypox vaccine candidates. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389680 | PubMed |
| 36304724 | Harnessing DNA for immunotherapy: Cancer, infectious diseases, and beyond. | Adv Funct Mater | 2022 | https://conductscience.org/library/papers/36304724 | PubMed |
| 35891431 | Combination of E- and NS1-Derived DNA Vaccines: The Immune Response and Protection Elicited in Mice against DENV2. | Viruses | 2022 | https://conductscience.org/library/papers/35891431 | PubMed |
| 35632789 | Development of DNA Vaccine Candidate against SARS-CoV-2. | Viruses | 2022 | https://conductscience.org/library/papers/35632789 | PubMed |
| 35284578 | Various vaccine platforms in the field of COVID-19. | Beni Suef Univ J Basic Appl Sci | 2022 | https://conductscience.org/library/papers/35284578 | PubMed |
| 34999210 | Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences. | Mol Ther | 2022 | https://conductscience.org/library/papers/34999210 | PubMed |
| 34975811 | Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34975811 | PubMed |
| 34914050 | Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34914050 | PubMed |
| 34705865 | The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. | PLoS One | 2021 | https://conductscience.org/library/papers/34705865 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24204366
GET https://conductscience.org/api/papers/v1/24204366/references?page=2